“In many ways, the bill requires the FDA to do things that it is already supposed to do—once more, with feeling,” says Avik Roy. He’s talking about a bill introduced by Sens. Richard Burr (R., N.C.) and Tom Coburn (R., Okla.) Among other things, it would:
- Retract the dumb 2007 conflict-of-interest rules for FDA advisory committees.
- Create more accountability for meeting drug-review deadlines.
- Stop forcing companies to do unnecessary and expensive busywork.
- Take more advantage of clinical trials in other countries.
More on the “PATIENTS’ FDA Act” in the Forbes.